A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

By sjmartinez • March 7, 2025

Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Feb 19;7(1):vdaf022. doi: 10.1093/noajnl/vdaf022. PMID: 40051661; PMCID: PMC11883343.

Tags: Cardiology/Epi, EGFR, FDG PET, Glioblastoma, imaging biomarker, molecular imaging, Osimertinib, Publications

Low Prevalence of Coronary Artery Calcium in High Cardiometabolic Risk Kenyan Adults with and Without HIV: The ASANTE Study

Shah H, Krishnan S, Narashim A, Korir S, Omondi G, Maxime Ale B, Gitura BM, Kinuthia J, Farquhar C, Hsue PY, Budoff M, Longenecker CT,[...]

Significance of 3-dimensional cardiac anatomical axis as the predictor of low QRS amplitude of subcutaneous implantable cardioverter-defibrillator

Uehara Y, Ueda N, Mori S, Kawabata T, Ishibashi K, Oshima T, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada[...]

Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Budoff MJ, Ronda N. Sex and reproductive stage modify the effect of endogenous oestrogens on[...]